Tetra Bio-Pharma Inc. (TSXV: TBP) (OTCQB: TBPMF) and Altus Formulation Inc. announced the launch of TALLC Corporation Inc. a new Quebec company focused on the development of TA-A001 a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. Altus […]





